MicroRNA for prediction of teratoma and viable germ cell tumor after chemotherapy Review


Authors: Baky, F. J.; Matulewicz, R. S.; Feldman, D. R.; Hamilton, R. J.; Bagrodia, A.
Review Title: MicroRNA for prediction of teratoma and viable germ cell tumor after chemotherapy
Keywords: cancer chemotherapy; treatment response; unclassified drug; overall survival; review; cisplatin; progression free survival; multiple cycle treatment; microrna; gene expression; etoposide; vincristine; prediction; risk factor; minimal residual disease; bleomycin; testicular cancer; drug sensitivity; germ cell tumors; testis teratoma; mirna; tumor markers; retroperitoneal lymphadenectomy; cancer prognosis; disease burden; human; cisplatin-resistance; testicular germ cell tumor; microrna 375; rna blood level; retroperitoneal lymph node dissection (rplnd); mir 367 3p; mir 371a 3p; mir 373 3p
Journal Title: Urologic Clinics of North America
Volume: 51
Issue: 3
ISSN: 0094-0143
Publisher: W.B. Saunders Co-Elsevier Inc.  
Date Published: 2024-08-01
Start Page: 387
End Page: 394
Language: English
DOI: 10.1016/j.ucl.2024.03.007
PROVIDER: scopus
PUBMED: 38925741
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Darren Richard Feldman
    340 Feldman
  2. Fady Baky
    12 Baky